• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高剂量维生素C对小鼠具有血管破坏作用的初步证据。

Preliminary Evidence That High-Dose Vitamin C has a Vascular Disrupting Action in Mice.

作者信息

Baguley Bruce C, Ding Qi, Richardson Emma

机构信息

Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland , Auckland , New Zealand.

出版信息

Front Oncol. 2014 Nov 5;4:310. doi: 10.3389/fonc.2014.00310. eCollection 2014.

DOI:10.3389/fonc.2014.00310
PMID:25414833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4220656/
Abstract

High intravenous doses of vitamin C (ascorbic acid) have been reported to benefit cancer patients, but the data are controversial and there is incomplete knowledge of what physiological mechanisms might be involved in any response. Vitamin C is taken up efficiently by cells expressing SVCT2 transporters and since vascular endothelial cells express SVCT2, we explored the hypothesis that administration of high-dose vitamin C (up to 5 g/kg) to mice might affect vascular endothelial function. A single administration of vitamin C to mice induced time- and dose-dependent increases in plasma concentrations of the serotonin metabolite 5-hydroxyindole acetic acid (5-HIAA), a marker for vascular disrupting effects. Responses were comparable to those for the tumor vascular disrupting agents, vadimezan and fosbretabulin. High-dose vitamin C administration decreased tumor serotonin concentrations, consistent with the release of serotonin from platelets and its metabolism to 5-HIAA. High-dose vitamin C also significantly increased the degree of hemorrhagic necrosis in tumors removed after 24 h, and significantly decreased tumor volume after 2 days. However, the effect on tumor growth was temporary. The results support the concept that vitamin C at high dose increases endothelial permeability, allowing platelets to escape and release serotonin. Plasma 5-HIAA concentrations could provide a pharmacodynamic biomarker for vitamin C effects in clinical studies.

摘要

据报道,静脉注射高剂量维生素C(抗坏血酸)对癌症患者有益,但数据存在争议,对于任何反应可能涉及的生理机制也了解不全面。表达SVCT2转运蛋白的细胞能够有效摄取维生素C,由于血管内皮细胞表达SVCT2,我们探究了向小鼠施用高剂量维生素C(高达5 g/kg)可能影响血管内皮功能的假说。给小鼠单次施用维生素C会导致血清素代谢物5-羟吲哚乙酸(5-HIAA)的血浆浓度出现时间和剂量依赖性增加,5-HIAA是血管破坏作用的标志物。其反应与肿瘤血管破坏剂vadimezan和磷丙泊酚二钠的反应相当。高剂量维生素C给药会降低肿瘤血清素浓度,这与血清素从血小板释放并代谢为5-HIAA一致。高剂量维生素C还显著增加了24小时后切除的肿瘤内出血性坏死的程度,并在2天后显著减小了肿瘤体积。然而,对肿瘤生长的影响是暂时的。这些结果支持了高剂量维生素C会增加内皮通透性,使血小板逸出并释放血清素这一概念。血浆5-HIAA浓度可为临床研究中维生素C的作用提供药效学生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/52c02c2bc265/fonc-04-00310-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/7bdcc3970f20/fonc-04-00310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/ea25054f956c/fonc-04-00310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/725a81b2f469/fonc-04-00310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/d3fde945a1b6/fonc-04-00310-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/52c02c2bc265/fonc-04-00310-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/7bdcc3970f20/fonc-04-00310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/ea25054f956c/fonc-04-00310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/725a81b2f469/fonc-04-00310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/d3fde945a1b6/fonc-04-00310-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9236/4220656/52c02c2bc265/fonc-04-00310-g005.jpg

相似文献

1
Preliminary Evidence That High-Dose Vitamin C has a Vascular Disrupting Action in Mice.高剂量维生素C对小鼠具有血管破坏作用的初步证据。
Front Oncol. 2014 Nov 5;4:310. doi: 10.3389/fonc.2014.00310. eCollection 2014.
2
Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.用黄酮 -8 - 乙酸、5,6 - 二甲基呫吨酮 -4 - 乙酸、长春碱和秋水仙碱治疗后血浆5-羟色胺增加:与血管效应的关系
Oncol Res. 1997;9(2):55-60.
3
Preclinical efficacy of vascular disrupting agents in non-small-cell lung cancer.血管破坏剂在非小细胞肺癌中的临床前疗效。
Clin Lung Cancer. 2011 Mar;12(2):81-6. doi: 10.1016/j.cllc.2011.03.001. Epub 2011 Apr 8.
4
DMXAA: an antivascular agent with multiple host responses.DMXAA:一种具有多种宿主反应的抗血管生成剂。
Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1503-11. doi: 10.1016/s0360-3016(02)03920-2.
5
Mechanisms of tumor vascular shutdown induced by 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Increased tumor vascular permeability.5,6-二甲基呫吨酮-4-乙酸(DMXAA)诱导肿瘤血管关闭的机制:肿瘤血管通透性增加。
Int J Cancer. 2005 Aug 20;116(2):322-6. doi: 10.1002/ijc.21005.
6
Sodium vitamin C cotransporter SVCT2 is expressed in hypothalamic glial cells.钠-维生素C共转运体2(SVCT2)在下丘脑神经胶质细胞中表达。
Glia. 2005 Apr 1;50(1):32-47. doi: 10.1002/glia.20133.
7
Increased expression of mitochondrial sodium-coupled ascorbic acid transporter-2 (mitSVCT2) as a central feature in breast cancer.线粒体钠依赖型抗坏血酸转运蛋白-2(mitSVCT2)表达增加是乳腺癌的一个主要特征。
Free Radic Biol Med. 2019 May 1;135:283-292. doi: 10.1016/j.freeradbiomed.2019.03.015. Epub 2019 Mar 19.
8
Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs.癌症患者血清素代谢的变化:其与化疗药物所致恶心和呕吐的关系。
Br J Cancer. 1992 Jul;66(1):198-203. doi: 10.1038/bjc.1992.242.
9
Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.使用静脉微透析监测顺铂诱导癌症患者血清素释放和代谢的变化:格拉司琼和昂丹司琼的比较效果
J Pharmacol Exp Ther. 1999 Dec;291(3):960-6.
10
High-dose vitamin C supplementation increases skeletal muscle vitamin C concentration and SVCT2 transporter expression but does not alter redox status in healthy males.大剂量维生素 C 补充可增加骨骼肌维生素 C 浓度和 SVCT2 转运体表达,但不会改变健康男性的氧化还原状态。
Free Radic Biol Med. 2014 Dec;77:130-8. doi: 10.1016/j.freeradbiomed.2014.09.013. Epub 2014 Sep 19.

引用本文的文献

1
The Vitamin C Enantiomers Possess a Comparable Potency in the Induction of Oxidative Stress in Cancer Cells but Differ in Their Toxicity.维生素C对映体在诱导癌细胞氧化应激方面具有相当的效力,但毒性不同。
Int J Mol Sci. 2024 Feb 22;25(5):2531. doi: 10.3390/ijms25052531.
2
The Use of Dietary Supplements and Amino Acid Restriction Interventions to Reduce Frailty in Pre-Clinical Models.膳食补充剂和氨基酸限制干预在减少临床前模型脆弱性中的应用。
Nutrients. 2022 Jul 8;14(14):2806. doi: 10.3390/nu14142806.
3
Evaluation of the antiaggregant activity of ascorbyl phenolic esters with antioxidant properties.

本文引用的文献

1
S-nitrosation of proteins: An emergent regulatory mechanism in microvascular permeability and vascular function.蛋白质的S-亚硝基化:微血管通透性和血管功能中一种新出现的调节机制。
Tissue Barriers. 2013 Jan 1;1(1):e23896. doi: 10.4161/tisb.23896.
2
Review of high-dose intravenous vitamin C as an anticancer agent.高剂量静脉注射维生素C作为抗癌剂的综述。
Asia Pac J Clin Oncol. 2014 Mar;10(1):22-37. doi: 10.1111/ajco.12173.
3
Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response.
具有抗氧化特性的抗坏血酸酚酯的抗聚集活性评估。
J Physiol Biochem. 2015 Sep;71(3):415-34. doi: 10.1007/s13105-015-0421-0. Epub 2015 Jun 17.
细胞内抗坏血酸增强低氧诱导因子 (HIF)-羟化酶活性,并优先抑制 HIF-1 转录反应。
Free Radic Biol Med. 2014 Apr;69:308-17. doi: 10.1016/j.freeradbiomed.2014.01.033. Epub 2014 Feb 2.
4
Hypoxia and metabolism in cancer.缺氧与癌症的代谢
Adv Exp Med Biol. 2014;772:1-39. doi: 10.1007/978-1-4614-5915-6_1.
5
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.随机对照的福司替尼联合紫杉醇/卡铂治疗间变性甲状腺癌的安全性和有效性研究。
Thyroid. 2014 Feb;24(2):232-40. doi: 10.1089/thy.2013.0078. Epub 2013 Sep 10.
6
Role of vitamin C in the function of the vascular endothelium.维生素 C 在血管内皮功能中的作用。
Antioxid Redox Signal. 2013 Dec 10;19(17):2068-83. doi: 10.1089/ars.2013.5205. Epub 2013 May 29.
7
Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer.卡铂和紫杉醇联合或不联合血管破坏剂vadimezan(ASA404)治疗晚期非小细胞肺癌的随机 III 期安慰剂对照试验。
J Clin Oncol. 2011 Aug 1;29(22):2965-71. doi: 10.1200/JCO.2011.35.0660. Epub 2011 Jun 27.
8
The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C.SLC23 家族的抗坏血酸转运体:确保你获得并保持每日所需的维生素 C 剂量。
Br J Pharmacol. 2011 Dec;164(7):1793-801. doi: 10.1111/j.1476-5381.2011.01350.x.
9
Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.药物性抗坏血酸与吉西他滨在胰腺癌的临床前模型中协同作用。
Free Radic Biol Med. 2011 Jun 1;50(11):1610-9. doi: 10.1016/j.freeradbiomed.2011.03.007. Epub 2011 Mar 12.
10
In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.有机阴离子转运体(OATs)在药物治疗中的重要性的体外和体内证据。
Handb Exp Pharmacol. 2011(201):29-104. doi: 10.1007/978-3-642-14541-4_2.